Novo Nordisk’s diabetes combination drug has been given the green light for marketing across the EU.
NHS England chief executive Simon Stevens has deemed obesity ‘the new smoking’, calling for urgent action to promote good health.
Janssen’s hepatitis C drug has been approved by NICE for use across the NHS in a limited capacity.
Merck Serono and Sutro Biopharma have entered an alliance to develop ADCs for cancer treatment.
National Institute for Health and Care Excellence (NICE) has fast-tracked its recommendation for a third new drug for melanoma, from GlaxoSmithKline (GSK), after the pharma firm offered to supply it at a discounted price to the NHS.
The NICE Board yesterday considered proposals on Value Based Assessment (VBA) following a three month consultation.
The BMA Wales has warned the NHS faces “imminent meltdown”, calling for an urgent independent enquiry.
Merck has announced new appointments to the Executive Board.
A trial of an experimental Ebola virus vaccine is to begin in Oxford. The trial is being fast tracked due to the speed and severity of the Ebola outbreak in West Africa.
A new report into alcohol misuse in Northern Ireland supports a reform of services as the cost to the tax payer reaches £900m each year.
AstraZeneca and Lilly are to partner up to develop and commercialise AZD3293, a potential drug for Alzheimer's disease.
Exp. Medical Reps and trainees. KAMs; eDetailing Reps Nationwide Opportunities
Click here to apply now!
“Opportunities nationwide with Boehringer Ingelheim”
Nationwide Sales and Marketing Opportunities available
Click here to apply!
No running polls, please check backsoon.
Increase your knowledge. Browse the Pf Archive.
Read Pf now
Looking to make a move? Find your next job here.
click here to createan account
Need career advice? Visit our Career Centre.